Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2019-2029

  • Single User License $3500

Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2019-2029

Status : May, 2021 | Medical Devices

Report Digest


Liquid Biopsy Market: Overview

The global liquid biopsy market is projected to gain momentum from the increasing cases of cancer worldwide. Liquid biopsy in a non-invasive method of testing blood that provides all the necessary details of the patient to the doctor or the lab physician. This technology is used as a monitoring tool for detecting information about the presence of a tumor via the blood sample. The fact that liquid biopsy is a non-invasive procedure is likely to help the market gain traction at a rapid pace in the coming years.

The report offers qualitative and quantitative analysis of the global liquid biopsy market and its growth parameters. This includes driving factors, repelling factors, challenging factors, and factors creating lucrative growth opportunities for the market. It also lists the number of players with their names and current position in the market competition. Furthermore, the report emphasizes on the impact of COVID-19 on the liquid biopsy market and its future predictions. Such information will help investors and other interested candidates to accordingly make financial decisions in terms of the future of this market.

The global liquid biopsy market is categorized on the basis of product, end user, cancer type, biomarker, and regions. In terms of product, the market is classified into service, instruments, and reagents. Based on end user, the market is bifurcated into academic & government research centers, and hospitals & laboratories. In terms of cancer type, the market is grouped into breast cancer, liver cancer, prostate cancer, lung cancer, colorectal cancer, and other cancers. With respect to segmentation by biomarker, the market is classified into circulating tumor DNA, extracellular vesicle circulating tumor cell, circulating biomarker, and others.

Liquid Biopsy Market: Competitive Landscape

Vendors functioning in the global liquid biopsy market are focusing on making heavy investments into clinical research and development. They are also engaging in merger and acquisition, product launches, joint ventures, and other collaborative efforts to stand out in the crowd and hold the highest liquid biopsy market share. The main objective of companies is to provide better therapeutics for cancer or other such diseases. The nature of market competition is highly fragmented on account of the presence of many players. Some of the players operating in this market are Menarini Silicon Biosystems, RainDance Technologies, Roche Diagnostics, Trovagene Inc., Rad Laboratories Inc., MDxHealth SA, Illumina Inc., Guardant Health Inc., Genomic Healthc Inc., Qiagen N.V., Thermo Fisher Scientific Inc.,Biocept Inc., Myriad Genetics Inc., and others.

Liquid Biopsy Market: Recent Innovations

The use of advanced technology, advent of minimally invasive procedures and other developments in the healthcare sector will also add boost to the overall growth of the market in the coming years. Besides this, the increasing cases of various tumors and cancer such as colorectal prostate, breast, liver, and others will also aid in expansion of the market in the coming years. Additionally, the increasing popularity of minimally invasive surgery, and advent of innovative technologies will help the market gain significant revenues in the forthcoming years.

Liquid Biopsy Market: Regional Segmentation

Based on regional segmentation, the global liquid biopsy market is widespread into the regions of North America, South America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is holding the highest share on account of the presence of well-established infrastructure and facilities. This, coupled with the presence of well-informed people and government-support in terms of reimbursement policies and medical insurance is expected to help North America continue to dominate the market in the coming years.

On the other side, the Asia Pacific market is expected to gain significant revenues in the coming years on account of the increasing adoption of latest healthcare diagnostic tools and procedure in the developing nations such as India, Japan, and China. Additionally, the increasing penetration of various medical companies into the aforementioned countries will also aid in expansion of the regional market in the coming years.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?